| 511 | Anti-Bacterial Agents (pharmacology) |
| 495 | Silver (chemistry) |
| 374 | Anti-Bacterial Agents (chemistry) |
| 360 | Silver (pharmacology) |
| 356 | Metal Nanoparticles (chemistry) |
| 343 | Microbial Sensitivity Tests (MeSH) |
| 331 | Humans (MeSH) |
| 273 | Escherichia coli (drug effects) |
| 209 | Animals (MeSH) |
| 202 | Staphylococcus aureus (drug effects) |
| 110 | Particle Size (MeSH) |
| 106 | Pseudomonas aeruginosa (drug effects) |
| 98 | Bacteria (drug effects) |
| 92 | Surface Properties (MeSH) |
| 88 | Biofilms (drug effects) |
| 87 | Nanocomposites (chemistry) |
| 86 | Microscopy, Electron, Transmission (MeSH) |
| 86 | Anti-Bacterial Agents (chemical synthesis) |
| 85 | Spectroscopy, Fourier Transform Infrared (MeSH) |
| 81 | X-Ray Diffraction (MeSH) |
| 80 | Mice (MeSH) |
| 80 | Metal Nanoparticles (MeSH) |
| 75 | Microscopy, Electron, Scanning (MeSH) |
| 74 | Metal Nanoparticles (ultrastructure) |
| 73 | Anti-Infective Agents (pharmacology) |
| 66 | Cell Survival (drug effects) |
| 66 | Anti-Bacterial Agents (administration & dosage) |
| 65 | Male (MeSH) |
| 61 | Silver (MeSH) |
| 59 | Escherichia coli (growth & development) |
| 54 | Materials Testing (MeSH) |
| 52 | Microbial Viability (drug effects) |
| 52 | Metal Nanoparticles (toxicity) |
| 51 | Titanium (chemistry) |
| 51 | Time Factors (MeSH) |
| 51 | Silver Compounds (pharmacology) |
| 51 | Female (MeSH) |
| 50 | Silver (administration & dosage) |
| 49 | Silver (toxicity) |
| 47 | Cell Line (MeSH) |
| 46 | Plant Extracts (chemistry) |
| 46 | Nanoparticles (chemistry) |
| 45 | Spectrophotometry, Ultraviolet (MeSH) |
| 41 | Staphylococcus aureus (growth & development) |
| 41 | Anti-Infective Agents (chemistry) |
| 40 | Light (MeSH) |
| 40 | Catalysis (MeSH) |
| 39 | Polymers (chemistry) |
| 39 | Chitosan (chemistry) |
| 38 | Metal Nanoparticles (administration & dosage) |
| 38 | Colony Count, Microbial (MeSH) |
| 38 | Bandages (MeSH) |
| 37 | Gram-Negative Bacteria (drug effects) |
| 36 | Gram-Positive Bacteria (drug effects) |
| 36 | Anti-Bacterial Agents (MeSH) |
| 35 | Dose-Response Relationship, Drug (MeSH) |
| 34 | Silver (metabolism) |
| 34 | Reactive Oxygen Species (metabolism) |
| 34 | Hydrogen-Ion Concentration (MeSH) |
| 33 | Anti-Bacterial Agents (toxicity) |
| 32 | Methicillin-Resistant Staphylococcus aureus (drug effects) |
| 32 | Escherichia coli (metabolism) |
| 32 | Biofilms (growth & development) |
| 31 | Wound Healing (drug effects) |
| 31 | Rats (MeSH) |
| 30 | Silver Compounds (chemistry) |
| 30 | Cells, Cultured (MeSH) |
| 29 | Titanium (pharmacology) |
| 28 | Drug Synergism (MeSH) |
| 27 | Water Purification (methods) |
| 27 | Plant Extracts (pharmacology) |
| 27 | Nanocomposites (ultrastructure) |
| 27 | Kinetics (MeSH) |
| 27 | Green Chemistry Technology (MeSH) |
| 27 | Graphite (chemistry) |
| 26 | Anti-Infective Agents, Local (pharmacology) |
| 25 | Temperature (MeSH) |
| 25 | Silver Nitrate (pharmacology) |
| 25 | Oxidation-Reduction (MeSH) |
| 25 | Coated Materials, Biocompatible (chemistry) |
| 25 | Blood Bactericidal Activity (MeSH) |
| 25 | Anti-Bacterial Agents (therapeutic use) |
| 25 | Adult (MeSH) |
| 24 | Coated Materials, Biocompatible (pharmacology) |
| 23 | Water Microbiology (MeSH) |
| 23 | Nanotechnology (MeSH) |
| 23 | Disinfectants (pharmacology) |
| 22 | Streptococcus mutans (drug effects) |
| 22 | Escherichia coli (ultrastructure) |
| 22 | Biocompatible Materials (chemistry) |
| 22 | Adsorption (MeSH) |
| 21 | Bacteria (growth & development) |
| 20 | Water (chemistry) |
| 20 | Spectrometry, X-Ray Emission (MeSH) |
| 20 | Silver Nitrate (chemistry) |
| 20 | Oxides (chemistry) |
| 20 | Middle Aged (MeSH) |
| 20 | Gold (chemistry) |
| 20 | Disinfection (methods) |
| 19 | Staphylococcus epidermidis (drug effects) |
| 19 | Staphylococcal Infections (drug therapy) |
| 19 | Porosity (MeSH) |
| 19 | Klebsiella pneumoniae (drug effects) |
| 19 | Ions (MeSH) |
| 19 | In Vitro Techniques (MeSH) |
| 19 | Anti-Bacterial Agents (metabolism) |
| 18 | Silicon Dioxide (chemistry) |
| 18 | Nanotechnology (methods) |
| 18 | Metal Nanoparticles (therapeutic use) |
| 18 | Escherichia coli (MeSH) |
| 18 | Chitosan (pharmacology) |
| 18 | Burns (drug therapy) |
| 18 | Biocompatible Materials (pharmacology) |
| 18 | Biocompatible Materials (MeSH) |
| 17 | Ultraviolet Rays (MeSH) |
| 17 | Staphylococcus aureus (physiology) |
| 17 | Plant Leaves (chemistry) |
| 17 | Photoelectron Spectroscopy (MeSH) |
| 17 | Photochemical Processes (MeSH) |
| 17 | Nanofibers (chemistry) |
| 17 | Microbial Sensitivity Tests (methods) |
| 17 | Cell Proliferation (drug effects) |
| 17 | Cell Membrane (drug effects) |
| 17 | Bacillus subtilis (drug effects) |
| 16 | Wound Infection (prevention & control) |
| 16 | Wound Infection (microbiology) |
| 16 | Staphylococcus aureus (MeSH) |
| 16 | Oxides (pharmacology) |
| 16 | Nanoparticles (ultrastructure) |
| 16 | Escherichia coli (radiation effects) |
| 16 | Burns (microbiology) |
| 15 | Wound Infection (drug therapy) |
| 15 | Silver (therapeutic use) |
| 15 | Pseudomonas aeruginosa (growth & development) |
| 15 | Nanoparticles (MeSH) |
| 15 | Microscopy, Atomic Force (MeSH) |
| 15 | Durapatite (chemistry) |
| 15 | Drug Resistance, Microbial (MeSH) |
| 15 | Bacterial Adhesion (drug effects) |
| 15 | Antifungal Agents (pharmacology) |
| 14 | Rabbits (MeSH) |
| 14 | Nanotubes (chemistry) |
| 14 | Nanostructures (chemistry) |
| 14 | Molecular Structure (MeSH) |
| 14 | Microbial Viability (MeSH) |
| 14 | Membranes, Artificial (MeSH) |
| 14 | Fibroblasts (drug effects) |
| 14 | Drug Resistance, Multiple, Bacterial (drug effects) |
| 14 | Drug Combinations (MeSH) |
| 14 | Copper (pharmacology) |
| 14 | Apoptosis (drug effects) |
| 14 | Adolescent (MeSH) |
| 13 | Pseudomonas aeruginosa (physiology) |
| 13 | Nanotubes, Carbon (chemistry) |
| 13 | Microscopy, Fluorescence (MeSH) |
| 13 | Hydrogels (chemistry) |
| 13 | Drug Resistance, Multiple, Bacterial (MeSH) |
| 13 | Disease Models, Animal (MeSH) |
| 13 | Chlorhexidine (pharmacology) |
| 13 | Antibodies, Bacterial (blood) |
| 12 | Treatment Outcome (MeSH) |
| 12 | Titanium (MeSH) |
| 12 | Structure-Activity Relationship (MeSH) |
| 12 | Silver (pharmacokinetics) |
| 12 | Phagocytosis (MeSH) |
| 12 | Glass (chemistry) |
| 12 | Gentamicins (pharmacology) |
| 12 | Escherichia coli (physiology) |
| 12 | Copper (chemistry) |
| 12 | Candida albicans (drug effects) |
| 11 | Zinc Oxide (chemistry) |
| 11 | Young Adult (MeSH) |
| 11 | Staphylococcus aureus (metabolism) |
| 11 | Silver Sulfadiazine (pharmacology) |
| 11 | Escherichia coli (cytology) |
| 11 | Drug Stability (MeSH) |
| 11 | Drug Resistance, Bacterial (drug effects) |
| 11 | Drug Resistance, Bacterial (MeSH) |
| 11 | Disinfection (MeSH) |
| 11 | Coated Materials, Biocompatible (MeSH) |
| 11 | Ciprofloxacin (pharmacology) |
| 11 | Bacterial Infections (prevention & control) |
| 11 | Bacterial Infections (drug therapy) |
| 11 | Anti-Bacterial Agents (biosynthesis) |
| 11 | Administration, Topical (MeSH) |
| 10 | Zinc Oxide (pharmacology) |
| 10 | Surface Plasmon Resonance (MeSH) |
| 10 | Staphylococcus aureus (ultrastructure) |
| 10 | Spectrum Analysis, Raman (MeSH) |
| 10 | Spectrum Analysis (MeSH) |
| 10 | Solutions (MeSH) |
| 10 | Solubility (MeSH) |
| 10 | Prosthesis-Related Infections (prevention & control) |
| 10 | Polymers (pharmacology) |
| 10 | Polyethylene Glycols (chemistry) |
| 10 | Plankton (drug effects) |
| 10 | Organometallic Compounds (pharmacology) |
| 10 | Nanoparticles (administration & dosage) |
| 10 | Mice, Inbred BALB C (MeSH) |
| 10 | Lipopolysaccharides (immunology) |
| 10 | Ions (chemistry) |
| 10 | Indoles (chemistry) |
| 10 | Hydrophobic and Hydrophilic Interactions (MeSH) |
| 10 | Green Chemistry Technology (methods) |
| 10 | Escherichia coli Infections (drug therapy) |
| 10 | Enterococcus faecalis (drug effects) |
| 10 | Disk Diffusion Antimicrobial Tests (MeSH) |
| 10 | Cell Line, Tumor (MeSH) |
| 10 | Biofilms (MeSH) |
| 10 | Bacterial Physiological Phenomena (drug effects) |
| 10 | Bacterial Infections (microbiology) |
| 10 | Antineoplastic Agents (pharmacology) |
| 10 | Antineoplastic Agents (chemistry) |
| 10 | Anti-Bacterial Agents (pharmacokinetics) |
| 9 | Zeolites (pharmacology) |
| 9 | Tensile Strength (MeSH) |
| 9 | Swine (MeSH) |
| 9 | Static Electricity (MeSH) |
| 9 | Staphylococcus (drug effects) |
| 9 | Staphylococcal Infections (microbiology) |
| 9 | Silver Compounds (therapeutic use) |
| 9 | Silver Compounds (chemical synthesis) |
| 9 | Rats, Sprague-Dawley (MeSH) |
| 9 | Microspheres (MeSH) |
| 9 | Microscopy, Electron (MeSH) |
| 9 | Meningococcal Vaccines (immunology) |
| 9 | Graphite (pharmacology) |
| 9 | Gold (pharmacology) |
| 9 | Durapatite (pharmacology) |
| 9 | Drug Liberation (MeSH) |
| 9 | Culture Media (MeSH) |
| 9 | Coated Materials, Biocompatible (chemical synthesis) |
| 9 | Child (MeSH) |
| 9 | Ceramics (chemistry) |
| 9 | Cattle (MeSH) |
| 9 | Burns (therapy) |
| 9 | Bacterial Proteins (genetics) |
| 9 | Bacteria (metabolism) |
| 9 | Analysis of Variance (MeSH) |
| 8 | Wound Healing (MeSH) |
| 8 | Water Pollutants, Chemical (toxicity) |
| 8 | Water (MeSH) |
| 8 | Staphylococcal Infections (prevention & control) |
| 8 | Silver Sulfadiazine (therapeutic use) |
| 8 | Silicon Dioxide (pharmacology) |
| 8 | Salmonella typhimurium (drug effects) |
| 8 | Rats, Wistar (MeSH) |
| 8 | Pseudomonas aeruginosa (metabolism) |
| 8 | Pseudomonas Infections (drug therapy) |
| 8 | Prostheses and Implants (MeSH) |
| 8 | Plant Extracts (metabolism) |
| 8 | Oxidative Stress (drug effects) |
| 8 | Nanocomposites (MeSH) |
| 8 | Mutation (MeSH) |
| 8 | Methicillin-Resistant Staphylococcus aureus (growth & development) |
| 8 | Gels (MeSH) |
| 8 | Fibroblasts (cytology) |
| 8 | Escherichia coli (genetics) |
| 8 | Diffusion (MeSH) |
| 8 | Cross Infection (prevention & control) |
| 8 | Cell Membrane Permeability (drug effects) |
| 8 | Cell Membrane (metabolism) |
| 8 | Bacterial Proteins (metabolism) |
| 8 | Antigens, Bacterial (immunology) |
| 8 | Antifungal Agents (chemistry) |
| 8 | Anti-Infective Agents (MeSH) |
| 8 | Aged (MeSH) |
| 8 | Acinetobacter baumannii (drug effects) |
| 7 | Zeolites (chemistry) |
| 7 | Thermogravimetry (MeSH) |
| 7 | Sunlight (MeSH) |
| 7 | Staphylococcus aureus (isolation & purification) |
| 7 | Spectrophotometry, Atomic (MeSH) |
| 7 | Spectrophotometry (MeSH) |
| 7 | Skin (drug effects) |
| 7 | Silver Nitrate (administration & dosage) |
| 7 | Silver (analysis) |
| 7 | Photochemistry (MeSH) |
| 7 | Occlusive Dressings (MeSH) |
| 7 | Neisseria meningitidis, Serogroup B (immunology) |
| 7 | Nanostructures (MeSH) |
| 7 | Nanofibers (ultrastructure) |
| 7 | Nanocapsules (chemistry) |
| 7 | NIH 3T3 Cells (MeSH) |
| 7 | Macrophages (drug effects) |
| 7 | Hydrogen Peroxide (pharmacology) |
| 7 | Hep G2 Cells (MeSH) |
| 7 | Hemolysis (drug effects) |
| 7 | HeLa Cells (MeSH) |
| 7 | Fungi (drug effects) |
| 7 | Fish Diseases (drug therapy) |
| 7 | Filtration (MeSH) |
| 7 | Escherichia coli (pathogenicity) |
| 7 | Electrophoresis, Polyacrylamide Gel (MeSH) |
| 7 | Electrochemical Techniques (MeSH) |
| 7 | Drug Delivery Systems (methods) |
| 7 | Drug Delivery Systems (MeSH) |
| 7 | Disinfectants (chemistry) |
| 7 | Delayed-Action Preparations (chemistry) |
| 7 | Cellulose (chemistry) |
| 7 | Cell Wall (drug effects) |
| 7 | Cell Shape (drug effects) |
| 7 | Cell Death (drug effects) |
| 7 | Carbon (chemistry) |
| 7 | Bacterial Outer Membrane Proteins (immunology) |
| 7 | Bacterial Adhesion (MeSH) |
| 7 | Antibodies, Bacterial (immunology) |
| 7 | Anti-Infective Agents, Local (administration & dosage) |
| 7 | Anti-Infective Agents (therapeutic use) |
| 7 | Anti-Infective Agents (chemical synthesis) |
| 7 | Acrylic Resins (chemistry) |
| 6 | Vancomycin (pharmacology) |
| 6 | Tissue Scaffolds (chemistry) |
| 6 | Sensitivity and Specificity (MeSH) |
| 6 | Salmonella enterica (drug effects) |
| 6 | Pseudomonas Infections (microbiology) |
| 6 | Phosphates (chemistry) |
| 6 | Oxidative Stress (MeSH) |
| 6 | Organometallic Compounds (chemistry) |
| 6 | Neisseria meningitidis (immunology) |
| 6 | Nanotubes (ultrastructure) |
| 6 | Nanocapsules (administration & dosage) |
| 6 | Models, Chemical (MeSH) |
| 6 | Models, Biological (MeSH) |
| 6 | Microwaves (MeSH) |
| 6 | Metals, Heavy (pharmacology) |
| 6 | MCF-7 Cells (MeSH) |
| 6 | Lipopolysaccharides (isolation & purification) |
| 6 | Hydrogels (pharmacology) |
| 6 | Hot Temperature (MeSH) |
| 6 | Glass (MeSH) |
| 6 | Flow Cytometry (MeSH) |
| 6 | Fish Diseases (microbiology) |
| 6 | Equipment Design (MeSH) |
| 6 | Equipment Contamination (prevention & control) |
| 6 | Electricity (MeSH) |
| 6 | Drug Design (MeSH) |
| 6 | Crystallography, X-Ray (MeSH) |
| 6 | Colloids (chemistry) |
| 6 | Child, Preschool (MeSH) |
| 6 | Cell Survival (physiology) |
| 6 | Cell Adhesion (drug effects) |
| 6 | Catalase (metabolism) |
| 6 | Candida albicans (growth & development) |
| 6 | Bromides (chemistry) |
| 6 | Bismuth (pharmacology) |
| 6 | Biofouling (prevention & control) |
| 6 | Bandages (microbiology) |
| 6 | Antioxidants (pharmacology) |
| 6 | Anti-Infective Agents, Local (therapeutic use) |
| 6 | Anti-Infective Agents (administration & dosage) |
| 6 | Anti-Bacterial Agents (adverse effects) |
| 6 | Alginates (chemistry) |
| 5 | Water Purification (instrumentation) |
| 5 | Water Pollutants, Chemical (chemistry) |
| 5 | Vibrio (drug effects) |
| 5 | Urinary Tract Infections (prevention & control) |
| 5 | Toxicity Tests (MeSH) |
| 5 | Sterilization (MeSH) |
| 5 | Staphylococcus epidermidis (growth & development) |
| 5 | Staphylococcus aureus (pathogenicity) |
| 5 | Staphylococcus aureus (cytology) |
| 5 | Species Specificity (MeSH) |
| 5 | Silver Sulfadiazine (administration & dosage) |
| 5 | Silver Compounds (administration & dosage) |
| 5 | Silver Compounds (MeSH) |
| 5 | Silver (adverse effects) |
| 5 | Serotyping (MeSH) |
| 5 | Salmonella typhimurium (growth & development) |
| 5 | Reproducibility of Results (MeSH) |
| 5 | Reactive Oxygen Species (MeSH) |
| 5 | Prosthesis Design (MeSH) |
| 5 | Polyvinyl Alcohol (chemistry) |
| 5 | Polymers (MeSH) |
| 5 | Polyethyleneimine (chemistry) |
| 5 | Polyesters (MeSH) |
| 5 | Platinum (chemistry) |
| 5 | Plasma Gases (chemistry) |
| 5 | Photolysis (MeSH) |
| 5 | Osteoblasts (drug effects) |
| 5 | Osteoblasts (cytology) |
| 5 | Organometallic Compounds (chemical synthesis) |
| 5 | Oils, Volatile (pharmacology) |
| 5 | Nylons (MeSH) |
| 5 | Neutrophils (immunology) |
| 5 | Neisseria meningitidis, Serogroup B (genetics) |
| 5 | Nanoparticles (toxicity) |
| 5 | Nanocomposites (administration & dosage) |
| 5 | Mycobacterium tuberculosis (drug effects) |
| 5 | Molecular Weight (MeSH) |
| 5 | Molecular Sequence Data (MeSH) |
| 5 | Molecular Conformation (MeSH) |
| 5 | Models, Molecular (MeSH) |
| 5 | Mice, Inbred C57BL (MeSH) |
| 5 | Metals (pharmacology) |
| 5 | Metal Nanoparticles (analysis) |
| 5 | Mesenchymal Stem Cells (drug effects) |
| 5 | Meningococcal Vaccines (administration & dosage) |
| 5 | Magnetite Nanoparticles (chemistry) |
| 5 | Magnetic Resonance Spectroscopy (MeSH) |
| 5 | Lipopolysaccharides (metabolism) |
| 5 | Lipopolysaccharides (analysis) |
| 5 | Lasers (MeSH) |
| 5 | Keratinocytes (drug effects) |
| 5 | Infant (MeSH) |
| 5 | Indoles (pharmacology) |
| 5 | Hydrogen Peroxide (chemistry) |
| 5 | Hydrodynamics (MeSH) |
| 5 | Hexuronic Acids (chemistry) |
| 5 | Guinea Pigs (MeSH) |
| 5 | Green Fluorescent Proteins (metabolism) |
| 5 | Gram-Negative Bacterial Infections (veterinary) |
| 5 | Glucuronic Acid (chemistry) |
| 5 | Gelatin (chemistry) |
| 5 | Fruit (chemistry) |
| 5 | Food Microbiology (MeSH) |
| 5 | Escherichia coli (isolation & purification) |
| 5 | Enterococcus faecium (drug effects) |
| 5 | Enterobacteriaceae (drug effects) |
| 5 | Electrodes (MeSH) |
| 5 | Drug Evaluation, Preclinical (methods) |
| 5 | Drug Evaluation, Preclinical (MeSH) |
| 5 | Dogs (MeSH) |
| 5 | Delayed-Action Preparations (pharmacology) |
| 5 | Cross Infection (microbiology) |
| 5 | Colloids (MeSH) |
| 5 | Coated Materials, Biocompatible (administration & dosage) |
| 5 | Chronic Disease (MeSH) |
| 5 | Cell Survival (MeSH) |
| 5 | Cell Membrane (chemistry) |
| 5 | Catfishes (microbiology) |
| 5 | Burns (complications) |
| 5 | Biotechnology (MeSH) |
| 5 | Biodegradation, Environmental (MeSH) |
| 5 | Bacteria (MeSH) |
| 5 | Anti-Bacterial Agents (radiation effects) |
| 5 | Acrylamides (chemistry) |
| 5 | A549 Cells (MeSH) |
| 4 | Zirconium (chemistry) |
| 4 | Zinc (chemistry) |
| 4 | Zeolites (MeSH) |
| 4 | Wounds and Injuries (therapy) |
| 4 | Wound Infection (therapy) |
| 4 | Wound Healing (physiology) |
| 4 | Wettability (MeSH) |
| 4 | Viscosity (MeSH) |
| 4 | Virulence Factors (genetics) |
| 4 | Vancomycin (chemistry) |
| 4 | Triclosan (pharmacology) |
| 4 | Tobramycin (pharmacology) |
| 4 | Tissue Engineering (methods) |
| 4 | Textiles (MeSH) |
| 4 | Streptococcus pyogenes (drug effects) |
| 4 | Streptococcus agalactiae (drug effects) |
| 4 | Staphylococcus aureus (radiation effects) |
| 4 | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization (MeSH) |
| 4 | Spectrometry, Fluorescence (MeSH) |
| 4 | Skin (microbiology) |
| 4 | Silver (radiation effects) |
| 4 | Silicon (chemistry) |
| 4 | Salmonella typhi (drug effects) |
| 4 | Reactive Oxygen Species (chemistry) |
| 4 | Pseudomonas aeruginosa (genetics) |
| 4 | Pseudomonas aeruginosa (MeSH) |
| 4 | Prosthesis-Related Infections (microbiology) |
| 4 | Prostheses and Implants (microbiology) |
| 4 | Powders (MeSH) |
| 4 | Povidone (chemistry) |
| 4 | Polyurethanes (chemistry) |
| 4 | Polysaccharides (chemistry) |
| 4 | Polylysine (chemistry) |
| 4 | Polyethylenes (pharmacology) |
| 4 | Polyesters (chemistry) |
| 4 | Plant Gums (chemistry) |
| 4 | Plankton (growth & development) |
| 4 | Phylogeny (MeSH) |
| 4 | Peptides (pharmacology) |
| 4 | Penicillium (metabolism) |
| 4 | Oxygen (chemistry) |
| 4 | Osteogenesis (drug effects) |
| 4 | Osmolar Concentration (MeSH) |
| 4 | Nitrophenols (chemistry) |
| 4 | Nanotubes, Carbon (ultrastructure) |
| 4 | Nanostructures (ultrastructure) |
| 4 | Nanomedicine (MeSH) |
| 4 | Nanofibers (MeSH) |
| 4 | Nanocapsules (ultrastructure) |
| 4 | Muramidase (pharmacology) |
| 4 | Models, Theoretical (MeSH) |
| 4 | Microscopy, Electron, Transmission (methods) |
| 4 | Microscopy, Confocal (MeSH) |
| 4 | Microbial Viability (radiation effects) |
| 4 | Methylene Blue (chemistry) |
| 4 | Materials Testing (methods) |
| 4 | Mass Spectrometry (MeSH) |
| 4 | Magnetic Phenomena (MeSH) |
| 4 | Macrophages (microbiology) |
| 4 | Luminescent Measurements (MeSH) |
| 4 | Liposomes (chemistry) |
| 4 | Lipid Peroxidation (MeSH) |
